VF
ENTX icon

Virtu Financial’s Entera Bio ENTX Stock Holding History

Virtu Financial’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65K Buy
+36,921
New +$46.2K ﹤0.01% 1185
2024
Q2 		– Sell
-22,040
Closed -$37K – 1455
2024
Q1 		$37K Buy
+22,040
New +$24.3K ﹤0.01% 1068
2021
Q1 		– Sell
-31,314
Closed -$34K – 1712
2020
Q4 		$34K Buy
+31,314
New +$34.6K ﹤0.01% 1299

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Virtu Financial's ENTX Position: Q2 2026 in Review

Virtu Financial opened a new position in Entera Bio (ENTX) in Q2 2026: 36,921 shares worth $65K. The stake represents ﹤0.01% of the portfolio and ranks #1185 among its holdings. This is a return to the name: Virtu Financial previously reported a position in ENTX as recently as Q1 2024.

Virtu Financial first reported a position in ENTX in Q4 2020 and has held it in 3 quarters since. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Virtu Financial held 36,921 shares of Entera Bio worth $65K as of Q2 2026.
  • Entera Bio was a new Virtu Financial position in Q2 2026.
  • Entera Bio made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1185 holding.
  • Virtu Financial first reported a position in Entera Bio in Q4 2020 and has held it in 3 quarters since.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.